HRTX News and Press, Heron Therapeutics Inc. From 03/24/23

2023-03-24 08:36:57 ET The futures were pointing to a decline at the start of Friday's trading. Stocks gained the day before in choppy trading, as strength in technology overcame weakness in other parts of the market. Here are some stocks to watch on Friday: Deutsche Bank ( NYSE: ...

2023-03-24 00:49:20 ET The following slide deck was published by Heron Therapeutics, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Heron Therapeutics, Inc. 2022 Q4 - Results - Earnings Call Presentation

2023-03-23 21:08:06 ET Heron Therapeutics, Inc. (HRTX) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants David Szekeres – Executive Vice President, Chief Operating Officer Barry Quart – Chairman and Chief Executive Officer ...

2023-03-23 16:06:31 ET Heron Therapeutics press release ( NASDAQ: HRTX ): Q4 GAAP EPS of -$0.17 beats by $0.15 . Revenue of $30.03M (+45.4% Y/Y) beats by $2.79M . As of December 31, 2022, Heron had cash, cash equivalents and short-term investments of ...

Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates PR Newswire - Annual Net Product Sales Across the Company Grew 25% to $107.7 million in 2022, Compared to Annual Net Product Sales...

2023-03-22 17:35:12 ET Heron Therapeutics ( NASDAQ: HRTX ) is scheduled to announce Q4 earnings results on Thursday, March 23rd, after market close. The consensus EPS Estimate is -$0.36 (+33.3% Y/Y) and the consensus Revenue Estimate is $27.24M (+31.8% Y/Y). Over the l...

2023-03-22 17:35:12 ET Major earnings expected after the bell on Thursday include: Ideanomics ( IDEX ) Planet 13 Holdings ( OTCQX:PLNHF ) Spruce Power Holding Corporation ( SPRU ) Heron Therapeutics ( HRTX ) ADMA Biologics ( ADMA ) For further...

2023-03-18 14:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-03-16 18:45:17 ET Summary BioXcel Therapeutics, Inc. has just released results for the fourth quarter of 2022. Some analysts have expressed doubts about the commercial success of its Igalmi launch. The good growth in forms approved so far makes me very optimistic about th...

Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVIE™, Effective April 1, 2023 Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVI...